Experimental vaccination of Atlantic salmon (Salmo salar L.) against marine flexibacteriosis
-
Published source details
van Gelderen R., Carson J. & Nowak B. (2009) Experimental vaccination of Atlantic salmon (Salmo salar L.) against marine flexibacteriosis. Aquaculture, 288, 7-13.
Published source details van Gelderen R., Carson J. & Nowak B. (2009) Experimental vaccination of Atlantic salmon (Salmo salar L.) against marine flexibacteriosis. Aquaculture, 288, 7-13.
Actions
This study is summarised as evidence for the following.
| Action | Category | |
|---|---|---|
|
Use vaccinations Action Link |
 |
-
Use vaccinations
In 2007, a randomised, replicated, controlled study in Tasmania, Australia (van Gelderen et al., 2009) found vaccination against marine flexibacteriosis increased survival rates in salmon, Salmo salar. Salmon injected with a vaccine and adjuvant showed significantly lower mortality levels (11%) than a group given the vaccine only (39%), a group given the adjuvant only (54%) and an unvaccinated control group (50%). Four groups of salmon (32-38 individuals in each) were given different treatments: a vaccine against marine flexibacteriosis, a vaccine and an adjuvant, an adjuvant only and no injection. Salmon were exposed to marine flexibacteriosis eight weeks after vaccination. Fish were placed in 100l seawater tanks and exposed for one hour. Mortality levels were recorded.
